BVI Medical announced that it received FDA 510(k) clearance for its Leos (laser endoscopy ophthalmic system) for treating glaucoma. Waltham, Massachusetts–based BVI designed Leos for a more intuitive laser endoscopic cyclophotocoagulation (ECP) procedure. It aims to integrate seamlessly into the surgical workflow while treating glaucoma. The company says Leos is the only laser system that […]
BVI Medical
BVI Medical names a new CCO
Ophthalmic device company BVI Medical announced today that it has appointed Andrew Chang as its new chief commercial officer (CCO). Chang’s appointment comes as the Waltham, Massachusetts-based company enters its next phase of growth, according to a news release. The company said it has upcoming product launches and continued global expansion on the horizon. In […]
BVI raises $1B in capital funding for monofocal intraocular lens
BVI Medical today announced it completed a $1 billion strategic capital raise in partnership with asset management firm TPG. The investment fully refinances BVI’s existing debt and adds equity from TPG and new investors as the ophthalmic company looks to accelerate product development and expand its global footprint. “This investment marks a pivotal moment for […]
BVI acquires certain ophthalmic device assets from Croma
BVI announced that it acquired the ophthalmic viscoelastic device (OVD) assets from Croma, as the two will combine for an R&D collaboration in the future. Financial terms of BVI’s acquisition were not disclosed. The pair of companies outlined their forthcoming collaboration as a partnership for additional products that will come to the market in the […]
BVI appoints chief financial officer
BVI today said it appointed David Murray as chief financial officer, effective immediately. Murray will report directly to president and CEO Shervin Korangy. “David has joined BVI during a period of exceptional expansion for the business as we continue to build the fastest growing diversified ophthalmic business in the industry,” Korangy said in a news […]
